 BOSTON, Nov. 07, 2022 GLOBE NEWSWIRE -- TransCode Therapeutics, Inc. Nasdaq: RNAZ, the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that it will be presenting at the Sidoti Virtual Conference. TransCodes Chief Executive Officer, Michael Dudley, will describe the companys RNA-based scientific discoveries that it believes will significantly advance the treatment of cancer, including the companys lead therapeutic candidate treating metastatic disease which it is advancing into the clinic with its first-in-human clinical trial. The presentation will be webcast and an archived recording will be made available in the Investors section of the TransCode Therapeutics website. 